Description

Novorapid FlexPen is a prefilled insulin delivery device that contains insulin aspart, a rapid-acting insulin analog used to manage blood glucose levels in individuals with diabetes. It is particularly effective for controlling postprandial (after-meal) blood sugar spikes.

Key Features:

• Active Ingredient:
  • Insulin Aspart: Each milliliter contains 100 units of insulin aspart, providing a rapid onset of action that helps manage blood sugar levels effectively.
• Mechanism of Action:
  • Insulin aspart works by mimicking the body’s natural insulin response to food. It starts to lower blood sugar levels quickly after injection, typically within 10-20 minutes, peaking at about 1-3 hours, and lasting for approximately 3-5 hours.
• Indications:
  • Novorapid FlexPen is indicated for the treatment of diabetes mellitus in adults and children, used to control blood glucose levels in conjunction with a long-acting insulin or other diabetes medications.
• Administration:
  • The FlexPen is designed for subcutaneous injection and can be administered in the abdomen, thigh, or upper arm. It is important to rotate injection sites to avoid lipodystrophy (abnormal fat distribution).
• Dosage:
  • Dosage is individualized based on the patient’s blood glucose levels, dietary intake, and physical activity. Patients should follow their healthcare provider’s recommendations for dosing and timing relative to meals.
• Side Effects:
  • Common side effects may include:
    • Hypoglycemia (low blood sugar), which can cause symptoms like sweating, tremors, and confusion.
    • Injection site reactions such as redness, swelling, or itching.
    • Weight gain may occur with insulin therapy.
  • Severe allergic reactions are rare but possible.
• Precautions:
  • Patients should monitor their blood glucose levels regularly and be aware of the signs of hypoglycemia. It is important to adjust insulin doses in response to changes in diet, exercise, or illness.
• Interactions:
  • Insulin aspart may interact with other medications that affect blood sugar levels. Patients should inform their healthcare provider about all medications and supplements they are taking.

Conclusion: Novorapid FlexPen (Insulin Aspart 100 U/ml) is an effective rapid-acting insulin option for managing blood glucose levels in individuals with diabetes. Its convenient delivery system allows for easy administration, making it a practical choice for daily diabetes management. As with any insulin therapy, it should be used under the supervision of a healthcare professional to ensure optimal results and safety. Regular monitoring of blood glucose levels is essential for effective diabetes control.

• Very secured payment methods
• Shipping will be calculated on checkout
• Please note that price may increase due to exchange rate, ensure updated price before making payment